1.Study of Operative Approach of Temporary Cardiac Pacing Therapy in Patients with Acute Inferior Wall Myocardial Infarction Complicated by High Degree Atrioventricular Block
Qi LAI ; Xuefeng GUANG ; Shunan JING ; Ruhong LI ; Mingxian ZUO ; Qiming GAI
Journal of Kunming Medical University 2013;(9):110-112
Objective This study was purposed to analyze and summarize the vein temporary cardiac pacing therapy in patients with acute inferior wall myocardial infarction complicated by high degree atrioventricular block (AVB) . Methods One hundred and twelve patients with acute inferior wall myocardial infarction complicated by high degree AVB were selected as observation and research subjects, and they were treated by vein temporary cardiac pacing therapy. The safety, availability of different kinds of this surgical methods and the relationship between these surgical methods and complication were observed. Results Three out of 60 patients who were treated by ordinary temporary pacing electrode catheter were suffering from cardiac tamponade. No serious complications occurred when 52 patients were treated by floating temporary pacing electrode catheter. Conclusion Floating temporary pacing electrode catheter have already proved safe and effective in the treatment of acute inferior wall myocardial infarction complicated by AVB, and it could decrease the incidence of serious complications such as myocardial perforation.
2.Application of Thrombus Aspiration Catheter in Percutaneous Intervention Therapy for Unstable Angina with No-reflow Phenomeno
Qi LAI ; Xuefeng GUANG ; Xiaolong YIN ; Mingxian ZUO ; Shunan JING ; Jie FANG
Journal of Kunming Medical University 2016;37(11):51-54
Objective To analyze and summarize the treatment strategies for unstable angina with no-reflow phenomenon after PTCA during early percutaneous interventional procedures.Methods A total of 32 cases with unstable angina were divided into two groups:one group with drug therapy and the other group with drug therapy and thrombus aspiration catheter.The patients were chosen when there was no-reflow phenomenon after PTCA during early percutaneous interventional procedures and their clinical data were compared and analyzed.Blood flow TIMI grade,myocardial perfusion grade (MBG),TIMI myocardial perfusion (TMP) grade and other indexes were observed and recorded.Results The general conditions had no statistical difference between two groups.Compared with the drug therapy group,the proportion of patients with TIMI,MBG and TMP grade 3 was higher in aspiration and drug therapy group (89% VS 71% P<0.05).Conclusion Drug therapy and thrombus aspiration catheter in treatment helps to improve myocardial perfusion level for unstable angina with no no-reflow phenomenon after PTCA during early percutaneous interventional procedures.
3.Effect of Xanthnotoxol on Contractility of Isolated Rabbit Ileum
Xiao HU ; Li ZHOU ; Qi-Shen LIAN ; Jing ZHENG ; Jing-Ge YANG ; Fei LAI
China Journal of Chinese Materia Medica 2001;26(1):56-58
Objective: To study the effects of Xanthnotoxol on contractility of isolated rabbit ileum and its relationship with Ca2+. Method: Routime experimental methods for isolated ileum were adopted. Result: Xanthnotoxol (XT) and Verapamil (Ver) inhibited the contraction of iso lated rabbit ileum smoth muscle induced by submaximal concentrations of acetylcholine (ACh) and serotonim (5-TH), with a IC50 value (μmol*L-1) of 10.495±1.521,0.428±0.001and 18.132±1.627,0.249±0.003,respectively. XT and Ver inhibited the contraction induced by Ca2+after high K+ depolorization and for noncompetitively antagonist CaCl2 cumulative dose-response curve, the pD'2 value was 4.69±0.03 and 6.35±0.10, respectively. XT (10μmol*L-1)and Ver(0.06μmol*L-1)inhibited the contraction induced by ACh in Ca2+-free medium, while XT (100μmol*L-1)but not Ver(0.6μmol*L-1) inhibited the extracellar Ca2+-dependent contraction induced by ACh. Conclusion: XT has a calcium-antagonistic effect which was not similar to that of Ver.
4.Effect of changji'an on visceral hypersensitivity in rats with irritable bowel syndrome and its mechanism.
Qi ZHU ; Jing WANG ; Hua-mei LAI
Chinese Journal of Integrated Traditional and Western Medicine 2008;28(9):813-817
OBJECTIVETo explore the mechanism and efficiency of Changji'an (CJA) in treating irritable bowel syndrome through studying the relationship between serotonin transporter (SERT) and visceral hypersensitivity in rats.
METHODSMale SD rats were randomly divided into 4 groups: the normal control group, the model group, the high-dosage and low-dosage CJA (CJAH and CJAL) groups. Visceral hypersensitivity model was established by colorectal distension. Normal saline and different doses of CJA were administrated to rats respectively, starting from the 10th day of modeling for 10 days. After then, the abdominal withdrawal reflex (AWR) was scored for semi-quantitative estimation of visceral sensitivity, and tissues of brain and colon were harvested for detecting expressions of SERT and serotonin (5-HT) with Western blot, real-time PCR and immunohistochemistry.
RESULTSAs compared with the normal controls, in model rats, the AWR score and content of 5-HT in intestinal mucosa were higher (P < 0.05), protein and mRNA expressions of SERT in colon and nucleus raphes dorsalis (NRD) were lower (P < 0.05), but all these indexes were improved significantly after CJA treatment, either in the CJAH or CJAL group (all P < 0.05). Besides, the number of 5-HT energic neuron in the model group and CJA groups was lower than that in the normal control group (P < 0.05).
CONCLUSIONCJA has therapeutic effect for improving visceral hypersensitivity in irritable bowel syndrome by way of regulating colonic expression of SERT and content of 5-HT.
Animals ; Disease Models, Animal ; Drugs, Chinese Herbal ; administration & dosage ; Humans ; Irritable Bowel Syndrome ; drug therapy ; genetics ; metabolism ; Male ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Serotonin ; metabolism ; Serotonin Plasma Membrane Transport Proteins ; genetics ; metabolism ; Viscera ; drug effects ; metabolism
5.Effects of D-galactose combined with lesions of nucleus basalis of Meynert on hippocampal long-term potentiation and synaptic morphology.
Yan RAO ; Jie GAO ; Shi-Long LAI ; Jing-Qing HU ; Qi WANG
Chinese Journal of Applied Physiology 2002;18(1):18-22
AIMTo study the changes of synaptic plasticity in rat model with Alzheimer disease (AD).
METHODSAD rat model was conducted by D-galactose intraperitoneal injection combined with lesions of nucleus basalis of Meynert (nbM). Behavioral performance, LTP in dentate gyrus and synaptic morphology in hippocampal CA1 were observed.
RESULTS(1) Escape latencies in place test in model rats were longer than that in control rats, and swimming time and distance between the two groups in platform quadrant were significant differently (P < 0.01). (2) The numerical density (Nu) and surface density (Su) of synaptic contact zones markedly decreased (P < 0.01) in model rats. (3) Augment of population spike (PS) in perforant path-dentate gyrus of model rats after high frequency stimulation was smaller than that of the control (P < 0.05).
CONCLUSIONThe results suggest that the decreased synaptic plasticity in hippocampus could responsible for the impairment of spatial learning of model rats.
Alzheimer Disease ; physiopathology ; Animals ; Basal Nucleus of Meynert ; pathology ; Disease Models, Animal ; Female ; Galactose ; pharmacology ; Hippocampus ; physiopathology ; Long-Term Potentiation ; Male ; Neuronal Plasticity ; Rats ; Rats, Wistar
6.Study of biological safety of scaffold material with heterologous deproteinized bone.
Lei LIU ; Kang-lai TANG ; Liu YANG ; Yue-kui JING ; Qi-hong LI
Chinese Journal of Traumatology 2006;9(4):234-237
OBJECTIVETo evaluate the biological safety of manufactured heterologous deproteinized bone and to provide an experimental basis for clinical applications.
METHODSDeproteinized bone (10 mm) and leaching liquor were made from pig ribs with a series of physical and chemical methods, then were evaluated through acute and subacute toxicity test, hemolysis test, pyrogen test, intracutaneous test, intramuscular implantation test and cytotoxity test.
RESULTSNo obvious toxicity, hemolysis, pyrogenic characteristics, skin irritation, inflammatory reaction after intramuscular implantation and cytotoxity were observed.
CONCLUSIONSThe heterologous deproteinized bone has good biological safety and meets all the demands of scaffold material for tissue engineering.
Animals ; Bone Transplantation ; Cytotoxicity Tests, Immunologic ; Hemolysis ; Mice ; Rabbits ; Tissue Engineering ; Transplantation, Heterologous
7.Study on karyotype of 306 cases of myelodysplastic syndrome.
Jing-Ying QIU ; Yue-Yun LAI ; Ye CHAI ; Yan ZHANG ; Yan SHI ; Qi HE ; Hui DANG ; Dao-Pei LU
Journal of Experimental Hematology 2004;12(4):455-459
The purpose of this study was to explore the significance of abnormal karyotype in diagnosis and prognosis estimation of myelodysplastic syndrome (MDS). Chromosome analysis were performed in 306 cases of MDS using the short-term culture of bone marrow cell and G-banding technique, and in partial cases FISH technique was used for this analysis. 93 out of 306 cases were followed up. The results showed that 144 cases (47.1%) had clonal chromosome aberrations. The most common chromosomal aberrations included +8, translocation, complex or high complex karyotype, -7/7q-, 20q-/-20, trisomy 1 or partial trisomy 1, +11/+11q-, -9/9q-, +9/9q+, -Y, dup(1q), +21. The rate of abnormal karyotype in refractory anemia with erythroblasts (RAEB) and refractory anemia with erythroblasts-transformation (RAEBT) were much higher than in refractory anemia (RA) and refractory anemia with sideroblasts (RAS) (P < 0.05). The rate of abnormal karyotype among those cases with mutagen contact history were higher than those in cases without mutagen contact history. The patients with abnormal karyotype had a mean survival time much shorter than patients with normal karyotype (P < 0.005) and had a higher risk transforming into acute leukemia (P < 0.05). The worst outcome was observed in those patients with a complex or high complex karyotype, -7/7q- and trisomy 11. In conclusion, MDS is highly heterogeneous disorders and karyotype analysis is helpful for its diagnosis, treatment selection and prognosis estimation.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Child
;
Child, Preschool
;
Chromosome Aberrations
;
Female
;
Humans
;
Karyotyping
;
Male
;
Middle Aged
;
Myelodysplastic Syndromes
;
genetics
;
mortality
;
Prognosis
8.Liver targeting of cationic liposomes modified with soybean-derived sterylglucoside in vitro.
Jing SHI ; Xian-Rong QI ; Li YANG ; Ran FEI ; Lai WEI
Acta Pharmaceutica Sinica 2006;41(1):19-23
AIMTo construct a liposomal liver targeting delivery system by adding soybean-derived sterylglucoside (SG) to the cationic liposomes.
METHODSThe physico-chemical properties of SG modified cationic lipsomes were investigated using fluorescein sodium (FS) as a model drug, as well as the interaction of SG modified liposomes with HepG2 2. 2. 15 cells in the point of involvement of asialoglycoprotein receptor (ASGP-R) mediated transfection. Liver targeting of modified cationic liposomes were also investigated using liver perfusing technique, and hepatocytes and non-hepatocytes were separated and examined after perfusing.
RESULTSAll the formula yielded high incorporation efficiency (83.12% - 91.74%), small particle size (93.0 - 124.4 nm). The zeta potential of blank liposomes all showed positive values. The transfection efficiency of FS entrapped in SG-liposomes with HepG2 2.2. 15 was significantly higher than that of liposomes without modification. The transfection of SG-liposomes were reduced significantly by the 20/30 mmol galactose as a competitor of ASGP-R. All the cationic liposomes showed high level of liver uptake of FS. Compared with the uptake of non-hepatocytes of each respectively, only SG/Brij-35 liposomes showed difference in FS uptake by hepatocytes (P < 0.05).
CONCLUSIONIt showed that SG/Brij-35 modified cationic liposomes are potentially useful drug carrier to liver but may be affected by different modification.
Animals ; Carcinoma, Hepatocellular ; metabolism ; pathology ; Cations ; pharmacokinetics ; Cell Line, Tumor ; Cholestenes ; administration & dosage ; pharmacokinetics ; Drug Delivery Systems ; Galactose ; pharmacology ; Humans ; Liposomes ; Liver ; metabolism ; Liver Neoplasms ; metabolism ; pathology ; Male ; Particle Size ; Polyethylene Glycols ; administration & dosage ; pharmacokinetics ; Rats ; Transfection
9.Analysis of cytogenetic response in Ph+ chronic myeloid leukemia patients treated with interferon alpha.
Hong HONG ; Jing-Ying QIU ; Yue-Yun LAI ; Yan SHI ; Qi HE ; Hui DANG ; Dao-Pei LU
Journal of Experimental Hematology 2003;11(3):269-273
Ph chromosome occurs in nearly all patients with CML, and eliminating Ph-positive clone is a major target in the treatment of CML. IFN-alpha is a well-known effective treatment in chronic phase CML. The cytogenetic response and the prognostic factors in 128 CML patients treated with IFN-alpha were retrospectively studied. IFN-alpha administered singly at a dose of 3 million U/day for 2 - 3 times a week or in combination with either hydroxyurea (Hu), busulfan (Bu), low dose Ara-C or harringtonine. Karyotyping was examined by G-banding before and after IFN-alpha-based treatment. The results showed that all patients achieved complete hematological remission. Cytogenetic response occurred in 36 of 118 patients with standard t (9;22) translocation; 3 of these 36 patients had a complete cytogenetic response (Ph = 0), 13 had major cytogenetic responses (Ph < 35%) and 20 had minimal response (Ph > 35%). The total cytogenetic effectiveness was 13.6% (16/118). Four of seven patients with complicated variant translocation also achieved cytogenetic response, 2 of them had a major cytogenetic response and 2 had minimal response. Factors influenced the prognosis associated with cytogenetic response included sex, patient status at diagnosis and IFN-alpha administered singly or in combination with other chemotherapeutic agents. IFN-alpha could not prevent the progression of CML. It is concluded that Ph(+)CML patients with both standard and variant translocation had major cytogenetic response to IFN-alpha treatment at a dose of 6 - 9 million U/week in single or combination with Hu/Bu, however, IFN-alpha treatment could not prevent disease progression. Long term survival was also observed in patients with variant translocation treated with IFN-alpha. Regular cytogenesis examination in CML patients is necessary during IFN-alpha therapy, which is useful to reflect curative effect and progression of the disease.
Adolescent
;
Adult
;
Aged
;
Antineoplastic Agents
;
therapeutic use
;
Chromosome Aberrations
;
Chromosomes, Human, Pair 22
;
genetics
;
Chromosomes, Human, Pair 9
;
genetics
;
Cytogenetic Analysis
;
Female
;
Humans
;
Interferon-alpha
;
therapeutic use
;
Karyotyping
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
drug therapy
;
genetics
;
pathology
;
Leukemia, Myeloid, Chronic-Phase
;
drug therapy
;
genetics
;
pathology
;
Male
;
Middle Aged
;
Retrospective Studies
;
Translocation, Genetic
;
Treatment Outcome
10.The relationship of HBeAg status with HBV DNA loads, MELD scores in patients with acute-onchronic hepatitis B liver failure during terminal phases
Jing LAI ; Xue-Jun LI ; Shao-Quan ZHANG ; Qi-Huan XU ; Jian-Yun ZHU ; Wei-Min KE
Chinese Journal of Experimental and Clinical Virology 2012;26(1):51-53
Objective To investigate the relationship and clinical significances of HBeAg status with serum HBV DNA loads,model for end-stage liver disease (MELD) scores in patients with acute-on-chronic hepatitis B liver failure during terminal phase.Methods 120 fatal patients were enrolled.At three phases of 0 -14 d,15 -28 d and 29 -90 d before death,they were detected serum HBeAg,HBV DNA loads order meanwhile MELD scores were calculated.Results In 51 patients with HBeAg positive,HBV DNA levels were (5.25 ± 1.99),(5.45 ± 1.47) and (6.06 ± 1.77) log10 copies/ml while MELD scores were (30.33 ± 5.25 ),(26.36 ± 6.43 ) and (20.13 ± 6.47) respectively.In 69 patients with HBeAg negative,HBV DNA loads were (5.14 ± 1.84),(5.49 ± 1.75 ) and (4.62 ± 1.65 ) log10 copies/ml while MELD scores were 32.38 ± 9.95,28.17 ±6.82 and 26.19 ± 5.56 in sequence.Compared with the same phase between HBeAg-positive group and HBeAg-negative group,significant differences in both HBV DNA loads and MELD scores were found only at the phase of 29 - 90 d (P < 0.05 ).In multiple comparisons among three phases,regardless of the HBeAg status,there wasn't significant difference for HBV DNA loads (P >0.05).But increasing MELD scores are associated with the disease exacerbation and significant differences were found (P < 0.05).Conclusions To initiate acute-on-chronic hepatitis B liver failure,serum HBV DNA loads of HBeAg-positive patients are higher than that of HBeAg-negative ones.Once ACLF has been initiated,sustained high HBV DNA loads may promote the disease worsened and be fatal regardless of the HBeAg status.